Skip to main content
PLOS One logoLink to PLOS One
. 2024 May 15;19(5):e0281851. doi: 10.1371/journal.pone.0281851

Exposure to Zika and chikungunya viruses impacts aspects of the vectorial capacity of Aedes aegypti and Culex quinquefasciatus

Mônica Crespo 1, Duschinka Guedes 1, Marcelo Paiva 1,2, Mariana Sobral 1, Elisama Helvecio 1, Rafael Alves 1, George Tadeu 3, Claudia Oliveira 1, Maria Alice Varjal Melo-Santos 1, Rosângela Barbosa 1, Constância Ayres 1,*
Editor: Kelli L Barr4
PMCID: PMC11095752  PMID: 38748732

Abstract

Zika (ZIKV) and chikungunya (CHIKV) are arboviruses that cause infections in humans and can cause clinical complications, representing a worldwide public health problem. Aedes aegypti is the primary vector of these pathogens and Culex quinquefasciatus may be a potential ZIKV vector. This study aimed to evaluate fecundity, fertility, survival, longevity, and blood feeding activity in Ae. aegypti after exposure to ZIKV and CHIKV and, in Cx. quinquefasciatus exposed to ZIKV. Three colonies were evaluated: AeCamp (Ae. aegypti—field), RecL (Ae. aegypti—laboratory) and CqSLab (Cx. quinquefasciatus—laboratory). Seven to 10 days-old females from these colonies were exposed to artificial blood feeding with CHIKV or ZIKV. CHIKV caused reduction in fecundity and fertility in AeCamp and reduction in survival and fertility in RecL. ZIKV impacted survival in RecL, fertility in AeCamp and, fecundity and fertility in CqSLab. Both viruses had no effect on blood feeding activity. These results show that CHIKV produces a higher biological cost in Ae. aegypti, compared to ZIKV, and ZIKV differently alters the biological performance in colonies of Ae. aegypti and Cx. quinquefasciatus. These results provide a better understanding over the processes of virus-vector interaction and can shed light on the complexity of arbovirus transmission.

Introduction

Complex interactions between vectors and arboviruses determine the vectorial competence of a species and act in association with biotic and abiotic factors. This set composes the parameters of vectorial capacity, which is described as the potential of a species to transmit a pathogen. In this context, aspects of the vector’s biological performance stand out, such as age [1], reproductive capacity, longevity, blood feeding behavior and population density, which are considered determinants in the transmission process [2]. Studies have already demonstrated that the arbovirus infection influences the reproductive capacity of females of different species [39]. Modifications in longevity, survival, and in blood meal activity have also been associated with arbovirus exposure or infection [4, 7, 8].

The Zika (ZIKV) and chikungunya (CHIKV) viruses are RNA arboviruses from the Flaviviridae and Togaviridae families, respectively, which have quickly spread in recent years to various parts of the world, including Brazil [1012]. These pathogens are a major public health concern, as they cause infections in humans that can trigger neurological complications, such as the Guillain-Barré Syndrome [13] and the Congenital Zika Syndrome [14], as well as cardiac manifestations [15] and painful and disabling polyarthralgia [16].

Recife, a municipality located in the northeast region of Brazil, is known to have very favorable environmental conditions for mosquito reproduction and maintenance of high vector population densities. These conditions, when associated with vectorial capacity and presence of a susceptible human population, construct a scenario conducive to the rapid propagation of an arbovirus [17]. Additionally, the ability of the species Ae. aegypti and Ae. albopictus to transmit ZIKV [1821] and CHIKV [2224], is an important factor for the spread of these viruses in the Americas [11, 25]. Also, it should be considered that other highly anthropophilic local species may be involved in arbovirus transmission as secondary vectors [26]. Cx. quinquefasciatus, for example, is an abundant species in many parts of the world, including Brazil. However, most studies on its role in ZIKV transmission were only published as of 2016 [2733].

In general, the information available on different aspects of the vectorial capacity of Aedes aegypti is not sufficient to explain the dynamics of arbovirus transmission, especially after pathogenic infections, considering that viruses modulate several parameters of the biological performance of vectors, and the mechanisms responsible for this modulation are also not well understood [9]. Studies that address the various aspects of the vectorial capacity of species involved in the transmission of arboviruses can contribute to the elucidation of fundamental questions for guidance of vector population control programs. Thus, the present study aimed to evaluate the effect of exposure to ZIKV and CHIKV on fecundity, fertility, survival, longevity and blood meal activity in Ae. aegypti from the city of Recife (Pernambuco, Brazil) and in a laboratory colony, as well as the effect of ZIKV on Cx. quinquefasciatus, a laboratory colony, considering the same aspects, which are relevant for arbovirus transmission [4, 7, 3436].

Materials and methods

Study area

The study was carried out in Recife (8°03’S 34°52’W), capital of the state of Pernambuco, Brazil, located in the northeast region. In the dry season, rainfall is scarce in the region, but it can be intense in the rainy season (from April to July). The average annual rainfall in the city is 2155.5, according to the National Meteorology Institute (INMET), in the period from 1991 to 2020 [37]. The temperature and relative air humidity range from 22 to 32°C and from 70 to 90% at different times of the year [38]. Recife is an hyperendemic area, with multiple arboviruses circulating simultaneously, and it has been considered as the epicenter of the first Zika outbreak in Brazil [39].

Mosquito samples

Three different mosquito populations were used in the present study: two laboratory colonies (RecL and CqLab) and one natural population (AeCamp). The laboratory colony of Ae. aegypti (RecL) has been maintained without contact with larvicide or adulticide since 1996, when it was established from collections performed in the neighborhood of Graças, in Recife [40]. The other Ae. aegypti population, called AeCamp, came from the field, and was established through egg collections performed between 2017 and 2018, in 13 neighborhoods in Recife (Santo Amaro, Várzea, Afogados, Dois Irmãos, Apipucos, Monteiro, Ipsep, Boa Viagem, Nova Descoberta, Vasco da Gama, Cidade Universitária and Mustardinha). Experiments with AeCamp were carried out with individuals of the F2 generation. As for the Culex species, we have used the Cx. quinquefasciatus laboratory colony, known as CqSLab, which was originated in the municipalities of Ipojuca, Olinda and Jaboatão dos Guararapes (Metropolitan Region of Recife), and it has been maintained since 2011 [41].

Eggs were collected in the field using BR-OVT traps [38] and larvae and pupae were collected directly from the breeding sites, using a larval dipper. All colonies were kept in the insectary of the Entomology Department of the Instituto Aggeu Magalhães (IAM-FIOCRUZ-PE), under controlled conditions of temperature (26°C ± 1°C), relative humidity (50 to 90%) and photoperiod (14:10 h—L/D). Larvae and pupae were kept in breeding containers with potable water and were fed cat food (friskies®). Adult mosquitoes were kept in aluminum mesh cages (50 x 40 cm) and were fed with a 10% sucrose solution ad libitum on a daily basis. For females, blood feeding was offered weekly, in an artificial feeder, using defibrinated rabbit blood (Oryctolagus cuniculus).

Virus strains

ZIKV (BRPE243/2015) [42] and CHIKV (PE480/2016) strains were obtained from patients residing in the State of Pernambuco, Brazil, during the 2015 and 2016 outbreaks, respectively. These viruses were kindly provided by Dr. Marli Tenório (Virology Laboratory, FIOCRUZ–PE). Viruses were propagated in Vero cells and titered as described in Guedes et al. [30].

Artificial bloodmeal for virus infection

Two to three independent experiments were performed with ZIKV and CHIKV. Each experiment was performed with two groups for each colony (RecL, AeCamp and CqSLab): exposed to the virus (E) and non-exposed (NE, the control group). Two hundred adult females were used for the control groups (NE) and 300, for the test groups; they were aged between 7 and 10 days of emergence. In all groups, females were starved for 24 hours prior to oral exposure to the virus.

Oral blood-feeding was provided with an artificial feeder comprised of a Petri dish and Parafilm®, with a mixture of cultures of Vero cells inoculated with virus and defibrinated rabbit blood, in a volume of 10 mL, in a 1:1 ratio, as described in Guedes et al. [30]. The stock virus dose used was 106 and 109 plaque forming units per ml (PFU/ml), for ZIKV and CHIKV, respectively. The negative control was a mixture of equal volume of virus-free cell culture and defibrinated rabbit blood. Approximately 0.5 ml of each mixture was aliquoted for further titration. Females were exposed to a blood meal for one hour. All females had three more blood meals devoid of virus, after exposure to the virus, with the objective of evaluating blood meal activity and keeping them in active gonotrophic cycles for a better evaluation of longevity. These blood meals were provided once a week for three consecutive weeks.

Assessment of the biological parameters after exposure to viruses

For the analysis of the putative biological cost, groups were defined according to the results of exposure to the viruses. Thus, for ZIKV, groups were divided into three: not exposed (NE); exposed, but not infected (E) and exposed and infected (EI). This definition was possible, since all mosquitoes were processed individually, by RT-qPCR, to confirm the infection, following Guedes et al. protocol [30]. For CHIKV, groups were divided into two: not exposed (NE) and exposed and infected (EI), considering that, for this virus, infection rates were higher than ZIKV (above 90%), the number of exposed individuals and not infected was not enough for statistical analysis (representing 4 and 8% for RecL and AeCamp, respectively), and therefore those samples were discarded.

Approximately 24 hours after the blood meal, 50 engorged Ae. aegypti females from each experimental group were transferred to individual cages. This was the initial number of samples used for all biological cost assessments.

Fecundity and fertility assessment

On the 3rd day post-exposure (dpe), each cage received a container (measuring 3.14 cm3) to mimic an oviposition site that contained 30% grass infusion and, in the case of the experiments with Ae. aegypti, posture supports made of cardboard, measuring approximately 4 x 2 cm.

In the Ae. aegypti assays, cardboards were changed twice a week, in three gonotrophic cycles. The collected eggs were counted through a stereomicroscope to determine the fecundity rate of each female. After 15 to 20 days of quiescence, the eggs were placed in recipients containing 2 mL of 30% grass infusion to stimulate the synchronous hatching of the larvae. These were counted to estimate the individual fertility rate of each female. Fecundity and fertility analyses were performed in the first gonotrophic cycle.

In the Cx. quinquefasciatus assays, the recipients were removed from the individual cages after each oviposition (once a week), in three gonotrophic cycles. The number of eggs present in each collected raft were determined with the aid of a magnifying glass, up to 24 hours after laying. Larvae hatching percentage was evaluated approximately 72 hours after oviposition, because the eggs of this species do not go into quiescence. Fecundity and fertility analyses were performed with all eggs from the first gonotrophic cycle.

Survival and longevity assessment

Mortality notification was performed daily to assess survival and longevity. To detect viral infection, ten females in each experimental group of Ae. aegypti, were collected at three time points: 7, 14 and 21 dpe (days post exposure). There was a total of 20 females from each group until the end of life, which were also collected as they died throughout the experiment, to detect viral infection. For these, FTA—classic card Whatman® cards (cards), containing Manuka honey blend ® honey, were made available on the screens of the cages, from the 7th to the 14th dpe. All females contributed to survival, and longevity assessments up to the point at which they left the study. For the analysis of average lifetime (longevity), females collected on the 7th, 14th and 21st dpe were excluded.

For Cx. quinquefasciatus, we have collected females only when death occurred throughout the experiments. This was necessary to guarantee a minimum number of infected females for analysis of longevity and survival in this species, considering that data from experiments carried out by our group [30] and unpublished data show a lower rate of ZIKV infection in Cx. quinquefasciatus when compared to Ae. aegypti, we probably wouldn’t have enough samples to collect at all time points. Additionally, FTA classic card (Whatman® card) containing Manuka honey blend® were made available on the screens of all cages, from the 7th to the 14th dpe to ensure viral detection, through saliva collection, since females had not been collected on 7th, 14th and 21st dpe, as performed for Ae. aegypti.

Survival and longevity analysis was also performed among Ae. aegypti females in relation to viral load, represented by the RNA copy number (CN), detected by RT-qPCR. A cut-off point was determined to define the groups (with the highest and lowest viral loads) based on the median CN values found for the infected females.

Search for blood meal

To assess the influence of ZIKV exposure on the blood meal activity of Ae. aegypti, females were fed with blood devoid of virus at 7, 14 and 21 dpe, for 30 minutes. After each feeding event, the completely engorged females were selected and counted. For logistical reasons and a reduction in the number of females throughout the experiment, which would imply problems in statistical analysis, unfortunately it was not possible to evaluate all moments for all infections. For Cx. quinquefasciatus exposed to ZIKV and Ae. aegypti exposed to CHIKV, evaluations were carried out exclusively with the first post-exposure blood meal (7 dpe).

RNA extraction and RT-qPCR

Females collected at 7, 14 and 21 dpe, as well as those that died during the study, were placed separately in 1.5 ml microtubes, containing 300 μl of a mosquito diluent and stored at -80°C until RNA extraction and RT-qPCR, described in Guedes et al. [30], with some modifications. The primers used for detection of CHIKV and ZIKV viral particles are described in Lanciotti et al. [43, 44]. Virus detection was performed by quantitative RT-qPCR on a QuantStudio® 5 Real-Time PCR system (Thermo Fisher Scientific, Waltham, MA, USA), according to conditions described in Guedes et al. [30]. Cycle threshold values (Ct) were used to estimate the amount of viral RNA, using the standard curve as a reference for each RT-qPCR assay, obtained through isolated transcripts from the ZIKV BRPE243/2015 and CHIKV PE480/2016 strains, as described in Kong et al. [45]. Negative controls for the feeding experiment and RT-qPCR consisted of mosquitoes fed with virus-free blood and water, respectively.

Whole mosquitoes were processed, except for Ae. aegypti collected at 7 dpe, whose abdomens and thorax were analyzed separately from the heads. To calculate the infection rate (IR), the number of positive females was divided by the total number of analyzed samples. To calculate the dissemination rates (DR), head samples or positive cards were used, divided by the total number of positive samples. Females and cards with Ct lower than 38 were considered as positive.

The FTA cards were placed in 1.5 mL tubes and stored at -80°C until use. To prepare the inoculum, cards were cut using multipurpose scissors and placed in 1.5 mL tubes. Next, 400 μL of ultrapure water was added to each tube, following homogenization for 5 times for 10 seconds, with 5 minute-intervals. Finally, the cards were transferred to a 10 mL syringe and filtered to enable recovery of the eluate only. The prepared inoculums were stored at –80°C until RNA extraction and RT-qPCR were performed, following the same protocol used for detection of viral RNA in mosquitoes.

Statistical analysis

A descriptive analysis was performed: the variables were presented through graphs, followed by the presentation of the confidence interval and the p-value. Normality assumptions were made by applying the Shapiro Wilk tests. To assess the differences in means for the independent variables, the T-Student test was used, when the assumptions of normality were met. Otherwise, the Mann-Whitney test was applied, and the medians were evaluated. Also, the Bartlett test was used to assess homogeneity. When the assumption of homogeneity was met, the ANOVA mean test was used with Tukey’s post hoc test; if not, the median was evaluated by applying the Kruskal-Wallis test, with the post hoc test for Fisher’s test. The survival curve was determined using the Kaplan-Meier plot. The Cox test was applied to assess survival, and the proportionalities were evaluated using the Schoenfeld test. Conclusions were taken at a significance level of 5%. Results of the analysis were obtained using the R Core Team [46].

Ethics statement

Ethical committee: This project was approved by the Research Ethics Committee of the Instituto Aggeu Magalhães-Fiocruz, Brazil (CAAE: 51012015.9.0000.5190).

Results

Infection and dissemination rates of Zika (ZIKV) and chikungunya (CHIKV) viruses

Infection and dissemination rates varied between the viruses and colonies evaluated, being higher in the experiments carried out with the chikungunya virus (IR of 96.00% for RecL and 93.00% for AeCamp). The dissemination rates of the same virus ranged between 100.00% and 94.00% for RecL and AeCamp, respectively (Table 1). With Zika virus, these values were lower in CqSLab (22.50% IR and 57.00% DR), in relation to the two colonies of Ae. aegypti (Table 1).

Table 1. Zika (ZIKV) and chikungunya (CHIKV) virus infection (IR) and dissemination (DR) rates detected in laboratory Aedes aegypti (RecL), field Aedes aegypti (AeCamp) and laboratory Culex quinquefasciatus (CqSLab) colonies.

Virus Colonies IR DR
ZIKV RecL 75.00 90.00
AeCamp 68.00 70.00
CqSLab 22.50 57.00
CHIKV RecL 96.00 100.00
AeCamp 93.00 94.00

The percentage of positive cards varied among the colonies and viruses analyzed. In mosquitoes infected with ZIKV, the percentage rate was 30% for RecL, and 60% for AeCamp, while for CqSLab from the first experiment, the percentage was low: 14.28%. As cards from the negative control showed the presence of viral particles in two of the three experiments analyzed by RT-qPCR, it was not possible to analyze samples from the second and third experiments carried out with CqSLab. Surprisingly, no cards were found to be positive for CHIKV in the two colonies (RecL and AeCamp), and we have no explanation for this.

Females infected with ZIKV or CHIKV, from both colonies of Ae. aegypti, had similar viral load, comparing those who died or were collected in the periods from 8 to 14 and from 15 to 21 dpe. However, those infected with ZIKV, who died or were collected by the 7 dpe, had a lower viral load in both colonies (Table 2 and S1 Fig in S1 File). This difference was not observed among those infected with CHIKV (Table 2).

Table 2. Mean number of RNA copies (CN) detected at periods ≤7; 8 to 14 and 15 to 21 days post-exposure dpe to Zika virus or CHIKV, in colonies of Aedes aegypti in the field (AeCamp), in laboratory (RecL) and in laboratory colony Culex quinquefasciatus (CqSLab).

  Period
(days)
N Min Max Mean Median Standard deviation EP p value1 p value2 Significance
ZIKV AeCamp
≤ 7 21 8.99E+06 1.29E+12 9.56E+10 4.94E+09 2.87E+11 6.26E+10 < 0.001
0.037
≤ 7 * 8 to 14
8 to 20 20 2.96E+08 3.12E+12 6.74E+11 2.50E+14 9.3E+11 2.08E+11
15 to 21 17 2.89E+07 4.42E+12 3.97E+11 2.55E+10 1.05E+12 2.55E+11
RecL
≤ 7 28 1.99E+07 6.55E+11 5.07E+10 4.31E+08 1.46E+11 2.75E+10 < 0.001
0.002
≤ 7 * 8 to14
8 to 20 24 6.40E+07 5.07E+12 5.48E+11 1.46E+11 1.12E+12 2.3E+11 ≤ 7 * 15 to 21
15 to 21 13 9.00E+07 8.23E+12 1.09E+12 1.17E+11 2.37E+12 6.57E+11  
CHIKV AeCamp                    
≤ 7 17 6.52E+10 2.54E+12 1.14E+12 8.98E+11 8.75E+11 2.12E+11 0,030 0,806
8 to 20 19 4.61E+08 4.71E+12 1.42E+12 1.26E+12 1.54E+12 3.54E+11
15 to 21 17 4.00E+09 5.88E+12 1.29E+12 5.82E+11 1.73E+12 4.18E+11
RecL
≤ 7 23 1.E+07 8.09E+12 1.53E+12
1.61E+11 2.45E+12 5.12E+11 0,048 0,880
8 to 20 17 1.54E+10 7.5E+12 1.63E+12
3.58E+11 2.31E+12 5.61E+11
15 to 21 16 1.16E+10 4.33E+12 9.94E+11 3.99E+14 1.33E+12 3.32E+11  

The ZIKV viral load (number of RNA copies per mL—CN) was significantly higher (p = 0.019) among females from the RecL colony who underwent a second blood meal in blood free of viral particles, at 7 dpe). The mean number of RNA copies increased from 6,13E+06 among those who did not have a second meal, to 8,26E+06 among those who ingested blood at 7 dpe. As a function of time of life after infection, it was found that the CN was significantly higher among RecL females that had completed engorgement at 7 dpe (p = 0.003) and died between the 8th and 22nd dpe (Fig 1 and S1 Table in S1 File). Although it was not statistically significant (p = 0,075), there was an increase in CN in the period between 8 and 22 days in AeCamp (Fig 1 and S1 Table in S1 File).

Fig 1. Viral load (number of RNA copies of ZIKV–CN, per mL, detected by RT-qPCR), in Aedes aegypti colonies from the laboratory—RecL and field—AeCamp, infected with Zika virus (ZIKV), which completed blood meal on the 7th day post-exposure (dpe), in blood free of viral particles, as a function of post-exposure life span to the virus.

Fig 1

A: RecL colony; B: AeCamp colony. Notes: < 22 Rep—: females that did not have a blood meal at 7 dpe post-exposure to ZIKV and died until the 21st dpe; > = 22 Rep—: females that did not have a blood meal at 7 dpe post-exposure to ZIKV and died after the 21st dpe; < 22 Rep +: females who blood fed at 7 dpe to ZIKV and died until the 21 st dpe; > = 22 Rep +: females that had a blood meal at 7 dpe post-exposure to ZIKV and died after the 21st dpe.

Biological cost of infection with Zika (ZIKV) and chikungunya (CHIKV) viruses

In general, ZIKV and CHIKV had a significant impact on the parameters of vectorial capacity of the evaluated colonies. This impact negatively altered the reproductive capacity of females exposed to artificial oral infection by these arboviruses.

Survival and longevity

The analysis of the survival curve of the groups exposed to ZIKV, showed that the risk of death for females from RecL was about twice as high (E = 1.845: p = 0.014 and EI = 2.014: p = 0.003), compared to the control group (non-exposed—NE) (Fig 2A and S2 Table in S1 File). Mean lifespans for the three groups did not differ significantly: 33.36; 31.04 and 26.23 days for NE, E and EI, respectively. However, for AeCamp, there was no significant difference in survival between the three groups analyzed, as the risk of death was 1,289 for group E and 1,212 for EI (Fig 2B and S2 Table in S1 File). The average lifespan in AeCamp was also similar for the three groups: 34.19; 31.19 and 31.26 days, for NE, E and EI, respectively. Among Cx. quinquefasciatus females, survival (E = 1.300 and EI = 0.805) (Fig 2C and S3 Table in S1 File). and longevity (34, 73; 31, 34 and 39, 50 days, for NE, E and EI, respectively) were not altered among females exposed to ZIKV.

Fig 2.

Fig 2

Survival curve of Aedes aegypti females–laboratory colony–RecL, over 66 days of observation; field colony—AeCamp, over 80 days of observation, and laboratory colony of Culex quinquefasciatus—CqSLab, over 70 days of observation, after exposure to Zika virus (ZIKV). A–RecL colony; B–AeCamp colony; C–CqSLab colony.

Likewise, the results found for the RecL colony, after exposure to CHIKV, showed an impact of infection on survival, with a higher risk of death (3.963) for the EI group (Fig 3A and S4 Table in S1 File); however, this difference appeared only between day zero and the 20th day of observation (p = 0.001), i.e., it was not found after the 21st day (Fig 3B). The longevity of RecL females was also reduced by CHIKV infection: 38 and 17 days for NE and E, respectively (p = 0.002). On the other hand, in AeCamp, the survival curves showed no statistical difference between the two study groups (Fig 3C and S1-S5 Tables in S1 File). Longevity was 37.5 days for the control group (non-exposed–NE) and 32 days for the EI group.

Fig 3. Survival curves: individuals from Ae. aegypti from laboratory—RecL, over 70 days and field—AeCamp, over 69 days of observation, after exposure to chikungunya virus (CHIKV).

Fig 3

A—RecL Colony—observation period less than or equal to 20 days; B—RecL Colony—observation period longer than 20 days; C—AeCamp Colony–observation period of 69 days.

In general, there was no correlation between longevity and viral load. The only exception was observed for the longevity of CHIKV infected AeCamp females, where there was a correlation identified as negative (the greater the longevity, the lower the viral load detected, - 0.534, p = 0.033). It should be noted that, from this analysis, females collected while still alive were removed from analysis (S6 Table in S1 File).

Fecundity and fertility in the first gonotrophic cycle

Fecundity (average number of eggs) and fertility (average percentage of larvae hatching) were not altered by exposure to ZIKV among Ae. Aegypti from the RecL colony (Fig 4A and S7 Table in S1 File, in the first gonotrophic cycle (number of eggs in the NE group = 87.83; E = 79.13; EI = 82.07 and average hatching percentage NE = 67.36%; E = 66.31%; EI = 69.12%). In AeCamp, fecundity was also unaltered (number of eggs NE = 72.70; E: 70.40 and EI: 70.90) by exposure to ZIKV, although a significant reduction occurred in fertility (average percentage of hatching NE = 65.46%; E: 50.68% and EI: 49.38%) (Fig 4B and S7 Table in S1 File). In Cx. quinquefasciatus, these parameters were not altered among infected females. However, fecundity has been reduced in those exposed to the virus and which did not develop the infection (number of eggs = NE: 102.25; E: 76.90; EI: 92.67. (Fig 4C and S7 Table in S1 File).

Fig 4. Average number of eggs laid and average percentage of larval hatching in the first gonotrophic cycle of Aedes aegypti females–laboratory colony–RecL and field colony–AeCamp, and of Culex quinquefasciatus females–laboratory colony–CqSLab, after exposure to Zika virus (ZIKV).

Fig 4

Note: NE–Control (non-exposed); EI—exposed and infected. A: RecL Colony; B: AeCamp Colony; C: CqSLab Colony.

The results show that the fecundity of females from the RecL colony was not significantly altered by the infection with CHIKV in the first gonotrophic cycle. However, the infection impacted fertility, with a reduction in the median percentage of hatching from 63.48% in group NE to 40.67% in group EI (Fig 5 and S8 Table in S1 File). Differently, in AeCamp, CHIKV had an impact on fecundity, reducing the median number of eggs from 48 in NE to 38 in group EI. The fertility of this colony was also altered by the infection, with a reduction in the median percentage from 57.50% to 37.50%, between groups NE and EI, respectively (Fig 5 and S8 Table in S1 File).

Fig 5. Mean or median number of eggs and median percentage of hatching of Aedes aegypti larvae–laboratory colony—RecL and field colony—AeCamp, in the first gonotrophic cycle, after exposure to chikungunya virus (CHIKV).

Fig 5

Note: NE–Control (non-exposed); EI—exposed and infected. A: RecL Colony; B: AeCamp Colony.

As with longevity, the correlation between reproductive capacity variables (fecundity and fertility) and viral load (CN) was analyzed. For CHIKV-infected RecL, the correlation was positive between CN and fecundity (0.332, p = 0.011) and negative between CN and fertility (-0.388, p = 0.003). In AeCamp, infected with the same virus, there was no correlation between these parameters, as well as for all colonies infected with ZIKV (S6 Table in S1 File).

Blood feeding activity

The blood meal activity of RecL, AeCamp and CqSLab colonies was not altered by exposure to ZIKV and CHIKV, regarding the search for a second blood meal. Detailed numbers are shown in Table 3.

Table 3. Number and percentage of females of Aedes aegypti, from colonies RecL and AeCamp, and of Culex quinquefasciatus, from colony CqSLab, which completed the blood meal in weeks following exposure to Zika virus (ZIKV) and from colonies RecL and AeCamp exposed to chikungunya (CHIKV), in blood free of viral particles.

Virus Colonies dpe Groups Blood Meals p-value
Negative (-) Positive (+)  
No. % No. % Total number
ZIKV
RecL 7 Non-exposed 42 35.59 76 64.41 118 0.695
Exposed 16 43.24 21 56.76 37
Exposed and infected 22 38.6 35 61.4 57
14 Non-exposed 45 55.56 36 44.44 81 0.526
Exposed 15 51.72 14 48.28 29
Exposed and infected 14 43.75 18 56.25 32
21 Non-exposed 21 72.41 8 27.59 29
Exposed 7 43.75 9 56.25 16 0.085
Exposed and infected 14 77.78 4 22.22 18
AeCamp 7 Non-exposed 61 52.59 55 47.41 116 0.142
Exposed 24 64.86 13 35.14 37
Exposed and infected 30 57.69 22 42.31 52
14 Non-exposed 56 70 24 30 80 0.342
Exposed 31 62 19 38 50
Exposed and infected 18 56.25 14 43.75 32
CqSLab 7 Non-exposed 19 34.55 36 65.45 55 0.771
Exposed 15 28.85 37 71.15 52
Exposed infected 5 27.78 13 72.22 18
CHIKV RecL 7 Non-exposed 46 57.50 34 42.50 80 1,000
Exposed infected 43 56.58 33 43.42 76

Discussion

Relevant aspects of the biological performance of vector mosquitoes can be altered by the process of pathogen infection, e.g., parameters involved in vectorial capacity. This event may lead to a consequent change in the pattern of occurrence of an epidemic in a given epidemiological context [1]. Studies have shown the biological cost of arbovirus infection, namely reduced survival, longevity, reproductive capacity, blood feeding, among other impacts in mosquitoes. The different results found between them are explained by the direct relationship between the virus lineages and vectors involved [3, 58, 47]. Significant changes in reproductive capacity, for example, can limit the number of offspring of infected females and determine the transmission dynamics of an arbovirus. In general, this dynamic also occurs as a function of the age at which the vector acquires the infection, as well as survival and longevity [6, 15].

In this sense, the two species investigated here, suffered a negative impact on biological performance, especially on reproductive capacity, after exposure to Zika (ZIKV) or chikungunya viruses (CHIKV), with a reduction in the number of individuals for the subsequent generation. This has evolutionary implications, once any trait that may offer an adaptive advantage for the mosquito’s defense against viral infection is unlikely to be selected for. However, the ability of a vector to transmit a pathogen is multifactorial and, therefore, isolated assessments in any of its parameters must be made with caution [1].

Our results showed that the natural population (AeCamp) did not suffer any impact on its survival or longevity caused by the infection of both viruses. This may suggest that infected mosquitoes can keep transmitting the virus for long periods in the environment. The interaction between vectors and viruses, genetically determined and triggered by the adaptive process in an environment, can result in more efficient transmission dynamics, with less impact on the biological performance of Ae. aegypti [47].

On the other hand, for the Ae. aegypti colony, RecL, there was a significant reduction in survival when it was exposed and infected with both viruses. This result demonstrates a greater fragility of this colony, since the infection and dissemination rates for the two viruses were always higher when compared to the field population. It is known that the colonization process causes genetic diversity loss, which may impact on mosquito defense, metabolism, development, among other important traits for mosquito survival. Therefore, the results found in studies using laboratory colonies should always be interpreted with caution, before being extrapolated to what actually occurs in nature. The reduction in the survival rate and number of eggs laid by Ae. aegypti was associated with the process of adaptation to CHIKV infection, in a study developed by Sirisena, Kumar and Sunil [6]. The authors demonstrated that there is a negative regulation of genes involved in the egg laying pathway in infected females, through the analysis of transcript expression [6].

Previous studies have addressed cost on longevity [4] and survival [47] of Ae. aegypti populations infected by ZIKV. Petersen et al. [4], for example, used the ZIKV strain BRPE243/2015, the same strain used in the present study, to assess the reproductive capacity and longevity of Ae. aegypti collected in Rio de Janeiro, and they found a negative impact of the infection on the longevity of females. Thus, owing to genetic background and environmental factors, the viral strain used for infection in the laboratory should be considered, because especially in Ae. aegypti, the interaction between pathogen and vector can vary even between geographically close populations [47].

Similarly, the longevity of Ae. aegypti from Palm Beach County, Florida was also unaltered using the CHIKV strain LR2006-OPY1 [4]. However, the same study suggests that physiological restrictions on the evolution of CHIKV infection in Ae. albopictus result in biological cost on this species, considering that they found a significant reduction in longevity. Additionally, the body titer of female Ae. albopictus infected with CHIKV and longevity were inversely correlated. For Ae. aegypti, the authors reported no correlation between these parameters [48]. Considering that the viral load can impact the biological performance of infected mosquitoes, the correlation between the lifetime of infected females (group EI) by ZIKV or CHIKV and the number of RNA copies (CN) in all colonies was analyzed in this study. Differently from what was found by Reiskind et al. [48] for field Ae. aegypti, here there was a negative correlation between longevity and the number of RNA copies/mL–CN, for females of Ae. aegypti from the field population infected with CHIKV. These results suggest that a high viral load impact longevity, however, it should also be considered that the virus may reduce its replication, as a consequence of the functioning of the immune system throughout the mosquito’s life [48] which precludes a clear interpretation of these results. Studies report acute arbovirus replication in the first two days after infection, as well as a slow reduction in the virus body titer and elimination throughout the mosquito’s lifetime. This dynamic can vary between vector species and viruses, as well as between different vector tissues [49, 50].

The number of eggs laid in the first gonotrophic cycle was not altered by exposure and infection with ZIKV in the two colonies of Ae. aegypti. On the other hand, the fertility of the field colony, AeCamp, was significantly reduced even among females exposed to ZIKV. According to Li et al. [51], the ovaries of mosquitoes are affected by ZIKV on the second day after infection. Despite this fact, ZIKV did not reduce the fecundity of Ae. aegypti, as also found by Padilha et al. [3] and Resck et al. [5], for laboratory strain, and Silveira et al. [47], for field population sample (F1). In contrast, a field population in Rio de Janeiro showed a reduction in fecundity. Interestingly, in the same study, one of the groups infected by ZIKV showed an increase in this parameter, when compered the first and the third gonotrophic cycles [4].

The negative impact on AeCamp fertility suggested that the cost resulting from exposure to the virus was directed to the viability of the eggs, regardless of the establishment of the infection. Resck et al. [5] did not find an impact of ZIKV infection on the fertility of females from an Ae. aegypti from laboratory, corroborating the results reported in this paper for RecL. For the other hand, Ciota et al. [52] describe the adaptive process is a determining factor for viral replication, in the case of successful infection, with subsequent increase in the immune response and consequent impact on the biological performance of the mosquito vector. The same author tested a strain of Cx. pipiens adapted, in the laboratory, to the West Nile Virus and observed a reduction in fecundity in the second week of the experiment, after exposure to the virus, which did not occur with the non-adapted strain of the same species. This hypothesis can explain the results regarding the fertility of AeCamp obtained here, which had contact with the same strain used in these experiments, during the Zika fever epidemic in 2015.

Parameters of reproductive capacity, especially fertility, showed a biological cost for infection with CHIKV, for both colonies, from the laboratory or field. Resck et al. [5] evaluated the reproductive capacity of Ae. aegypti after infection with CHIKV and found a negative effect on fertility, but not on fecundity to laboratory colonie. A similar result was found with the CHIKV strain and Ae. albopictus field population from the Italy. This alteration in fertility suggests that CHIKV can affect embryonic development and embryo survival [34] as described for other viruses [4, 7]. This may also explain the negative correlation found in this study between the viral load and the fertility of the laboratory Aedes aegypti colony. The relevant effect of CHIKV and ZIKV infection on fertility, found in this study, suggests the need for further investigation, considering the variable time of interaction in the field between these arboviruses and the field populations, assuming that this as this seems to be a critical point in the relationship vector/parasite.

For Cx. quinquefasciatus (CqSLab), survival and longevity were not affected by ZIKV exposure or infection. Styer, Meola and Kramer [7] found no difference in this aspect of vectorial capacity between Cx. tarsalis females, in a laboratory colony, after exposure to West Nile virus (WNV). The survival of Cx. tarsalis, however, was altered by Western equine encephalitis virus (WEEV) infection [53]. In this study, exposure to ZIKV, but not infection, impacted the reproductive capacity of females, significantly reducing fecundity. For a laboratory colony of Cx. pipiens, pre-selected by continuous exposure to a WNV strain, fecundity was also altered; however, unlike what was found in the present study, infection, not just exposure, reduced this parameter [52]. The fecundity and fertility of Cx. tarsalis infected by WNV was also reduced in the infected groups [7]. Additionally, the same authors reported that the percentage of larvae hatching was higher in the exposed group (65.8%), than in the non-exposed (55.6%) and exposed and infected groups (42.5%).

The results analyzed for post-exposure blood feeding activity in an artificial feeder suggest that there is no effect of exposure or infection on the search for subsequent blood feeding in Ae. aegypti and Cx. quinquefasciatus, for both viruses and colonies studied here, considering the criterion evaluated (percentage of females that completed the blood meal within 30 minutes of exposure to the feeder). On the other hand, when evaluating the time spent by females of Ae. aegypti to complete engorgement, Sylvestre, Gandini and Maciel-de-Freitas [8] found that infected females spent more time compared to the non-exposed group. Additionally, a higher percentage of females of Cx. tarsalis infected with WNV had a blood meal on artificial feedings after infection, compared with unexposed females and exposed females that had not been infected. However, the same authors reported no significant difference in the amount of blood ingested between the three groups evaluated [7].

In general, the findings suggest that exposure to ZIKV and CHIKV significantly impact the reproductive capacity and longevity of the colonies evaluated. CHIKV had a greater impact on Ae. aegypti, in comparison to ZIKV, considering both parameters of the reproductive capacity of the field mosquitoes as well as the fertility of RecL. The greater impact observed in CHIKV infection compared to ZIKV can be explained by the different dynamics of viral dissemination, in agreement with Resck et al. [5], or by the shorter extrinsic incubation period (around two days) observed for this virus by Fuller et al. [54], although ZIKV was detected in the ovaries and salivary glands as early as the second day after infection [51]. The fact that ZIKV did not alter the fecundity of Ae. aegypti, in our study, may be related to the low viral detection in ovaries, found by Nag et al. [55] on the tenth day after infection. The same authors reported an increased prevalence of ovarian infection after a second blood meal in blood free of viral particles [55]. It is noteworthy that, in this study, only the data from the first gonadotrophic cycle were statistically analyzed, since a robust analysis was not possible for the data collected in the second and third cycles (data not shown).

Only exposure to ZIKV, but not infection, was enough to reduce the fecundity of Cx. quinquefasciatus females, suggesting that the triggering of defense mechanisms associated with the midgut barriers generates a biological cost for the species. Although Cx. quinquefasciatus showed much lower infection and dissemination rates than Ae. aegypti, this species is much more abundant in the environment in Recife; thus, its role in ZIKV transmission is not clear yet. In Ae. aegypti, ZIKV infection reduced the fertility of field females, but not their fecundity. However, this impact may have little relevance, considering that longevity, survival and search for blood source after exposure to the virus were not affected in the field population.

In the colony of Ae. aegypti, females infected with ZIKV, which had a second blood meal at 7 dpe, had a significantly higher number of RNA copies, compared to those that did not have a second meal. Similarly, Cui et al. [56] reported a three to four-fold increase in viral load among Ae. aegypti infected with DENV-4 after blood feeding at 5 dpe. However, owing to the limited number of females analyzed for this aspect, new experiments should be carried out, as they may allow a better statistical evaluation of this relationship, involving other variables to possibly confirm this result.

In summary, the results presented here confirm the hypothesis that there is a negative impact of infection by the Zika and chikungunya viruses on the reproductive capacity parameters evaluated. However, this hypothesis has not been confirmed regarding the impact on longevity and hematophagous behavior. It is worth mentioning that a limitation of this study was the analysis of only samples from the first gonotrophic cycle which means that other effects of ZIKV and CHIKV infections in mosquitoes, that were not possible to be observed here, could be observed in later cycles, as pointed out by other authors [55, 57]. It is suggested, in the case of Ae. aegypti field population, that there was an adaptive process that favored these parameters, probably resulting from the previous contact of this mosquito population, during the ZIKV and CHIKV epidemics, between 2015 and 2016, with the virus strains studied here. In Cx. quinquefasciatus, the results showed lower susceptibility to ZIKV, which may justify the lower impact on this colony, as reported by Reiskind et al. [48].

Additionally, our results corroborate the hypothesis of Cx. quinquefasciatus participation in the ZIKV transmission process [30]. Finally, we highlight the relevance and novelty of this study, especially considering the lack of laboratory investigations to address aspects of blood-feeding behavior, after exposure to ZIKV and CHIKV, in Ae. aegypti and Cx. quinquefasciatus.

Supporting information

S1 File

(DOCX)

pone.0281851.s001.docx (295.7KB, docx)

Acknowledgments

The authors would like to thank the Reference Service for Control of Culicidae Vectors and the insectary team for their support and supply of mosquitoes. To the Secretary of Health of Recife. Larissa Krokovsky for help with RT-qPCR.

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

C.F.J.A: Grants APQ-1608-2.13/15 and APQ-0085-2.13/16, and M.H.S.P, grant APQ-0725-2.13/17. Fundação de Amparo à Pesquisa do Estado de Pernambuco (FACEPE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Mayton EH, Tramonte AR, Wearing HJ, Christofferson RC. Age-structured vectorial capacity reveals timing, not magnitude of within-mosquito dynamics is critical for arbovirus fitness assessment. Parasites Vectors. 2020;13(1): 310. doi: 10.1186/s13071-020-04181-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Kramer LD, Ciota AT. Dissecting vectorial capacity for mosquito-borne viruses. Curr Opin Virol. 2015;15: 112–118. doi: 10.1016/j.coviro.2015.10.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Padilha KP, Resck MEB, Cunha OAT, Teles-de-Freitas R, Campos SS, Sorgine MHF, et al. Zika infection decreases Aedes aegypti locomotor activity but does not influence egg production or viability. Mem Inst Oswaldo Cruz. 2018;113(10): e180290. doi: 10.1590/0074-02760180290 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Petersen MT, Silveira ID, Tátila-Ferreira A, David MR, Chouin-Carneiro T, van den Wouwer L, et al. The impact of the age of first blood meal and Zika virus infection on Aedes aegypti egg production and longevity. PLoS One. 2018;13(7): e0200766. doi: 10.1371/journal.pone.0200766 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Resck MEB, Padilha KP, Cupolillo AP, Talyuli OAC, Ferreira-de-Brito A, Lourenço-de-Oliveira R, et al. Unlike Zika, Chikungunya virus interferes in the viability of Aedes aegypti eggs, regardless of females’ age. Sci Rep. 2020;10(1): 13642. doi: 10.1038/s41598-020-70367-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Sirisena PDNN, Kumar A, Sunil S. Evaluation of Aedes aegypti (Diptera: Culicidae) life table attributes upon chikungunya virus replication reveals impact on egglaying pathways. J Med Entomol. 2018;55(6): 1580–1587. doi: 10.1093/jme/tjy097 [DOI] [PubMed] [Google Scholar]
  • 7.Styer LM, Meola MA, Kramer LD. West Nile virus infection decreases fecundity of Culex tarsalis females. J Med Entomol. 2007;44(6): 1074–1085. doi: 10.1603/0022-2585(2007)44[1074:wnvidf]2.0.co;2 [DOI] [PubMed] [Google Scholar]
  • 8.Sylvestre G, Gandini M, Maciel-de-Freitas R. Age-dependent effects of oral infection with dengue virus on Aedes aegypti (Diptera: Culicidae) feeding behavior, survival, oviposition success, and fecundity. PLoS One. 2013;8(3): e59933. doi: 10.1371/journal.pone.0059933 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Javed N, Bhatti A, Paradkar PN. Advances in Understanding Vector Behavioural Traits after Infection. Pathogens. 2021;10(11): 1376. doi: 10.3390/pathogens10111376 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Faria NR, Azevedo RSS, Kraemer MUG, Souza R, Cunha MS, Hill SC, et al. Zika virus in the Americas: sarly epidemiological and genetic findings. Science. 2016;352(6283): 345–349. doi: 10.1126/science.aaf5036 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Fernández-Salas I, Danis-Lozano R, Casas-Martínez M, Ulloa A, Bond JG, Marina CF, et al. Historical inability to control Aedes aegypti as a main contributor of fast dispersal of chikungunya outbreaks in Latin America. Antiviral Res. 2015;124: 30–42. doi: 10.1016/j.antiviral.2015.10.015 [DOI] [PubMed] [Google Scholar]
  • 12.Zanluca C, Melo VCA, Mosimann ALP, Santos GIV, Santos CND, Luz C. First report of autochthonous transmission of Zika virus in Brazil. Mem Inst Oswaldo Cruz. 2015;110(4): 569–572. doi: 10.1590/0074-02760150192 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Oehler E, Watrin L, Larre P, Leparc-Goffart I, Lastere S, Valour F, et al. Zika virus infection complicated by Guillain-Barré syndrome: case report, French Polynesia. Euro Surveill. 2014;19(9): 20720. doi: 10.2807/1560-7917.es2014.19.9.20720 [DOI] [PubMed] [Google Scholar]
  • 14.Albuquerque MFPM Souza WV, Araújo TVB Braga MC, Miranda-Filho DB Ximenes RAA, et al. The microcephaly epidemic and Zika virus: building knowledge in epidemiology. Cad Saúde Pública. 2018;34(10): e00069018. doi: 10.1590/0102-311X00069018 [DOI] [PubMed] [Google Scholar]
  • 15.Morrison TE. Reemergence of chikungunya virus. J Virol. 2014;88(20): 11644–11647. doi: 10.1128/JVI.01432-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Madariaga M, Ticona E, Resurrecion C. Chikungunya: bending over the Americas and the rest of the world. Braz J Infect Dis. 2016;20(1): 91–98. doi: 10.1016/j.bjid.2015.10.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Boyer S, Calvez E, Chouin-Carneiro T, Diallo D, Failloux A. An overview of mosquito vectors of Zika virus. Microbes Infec. 2018;20(11–12): 646–660. doi: 10.1016/j.micinf.2018.01.006 [DOI] [PubMed] [Google Scholar]
  • 18.Dick GWA, Kitchen SF, Haddow AJ. Zika virus (I): isolations and serological specificity. Trans R Soc Trop Med Hyg. 1952;46(5): 509–520. doi: 10.1016/0035-9203(52)90042-4 [DOI] [PubMed] [Google Scholar]
  • 19.Diallo D, Sall AA, Diagne CT, Faye O, Faye O, Ba Y, et al. Zika virus emergence in mosquitoes in Southeastern Senegal, 2011. PLoS One. 2014;9(10): e109442. doi: 10.1371/journal.pone.0109442 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Díaz-Quiñonez JA, López-Martínez I, Torres-Longoria B, Vázquez-Pichardo M, Cruz-Ramírez E, Ramírez-González JE, et al. Evidence of the presence of the Zika virus in Mexico since early 2015. Virus Genes. 2016;52(6): 855–857. doi: 10.1007/s11262-016-1384-0 [DOI] [PubMed] [Google Scholar]
  • 21.Guerbois M, Fernandez-Salas I, Azar SR, Danis-Lozano R, Alpuche-Aranda CM, Leal G, et al. Outbreak of Zika virus infection, Chiapas State, Mexico, 2015, and first confirmed transmission by Aedes aegypti mosquitoes in the Americas. J Infect Dis. 2016;214(9): 1349–1356. doi: 10.1093/infdis/jiw302 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Restrepo-Jaramillo BN. Infección por el virus del chikungunya. CES Medicina. 2014;28(2): 313–323. [Google Scholar]
  • 23.Enserink M. Infectious diseases: massive outbreak draws fresh attention to little-known virus. Science. 2006;311(5764): 1085. doi: 10.1126/science.311.5764.1085a [DOI] [PubMed] [Google Scholar]
  • 24.Tsetsarkin KA, Vanlandingham DL, McGee CE, Higgs S. A single mutation in chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog. 2007;3(12): 1895–1906. doi: 10.1371/journal.ppat.0030201 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Chouin-Carneiro T, Vega-Rua A, Vazeille M, Yebakima A, Girod R, Goindin D, et al. Differential susceptibilities of Aedes aegypti and Aedes albopictus from the Americas to Zika virus. PLoS Negl Trop Dis. 2016;10(3): e0004543. doi: 10.1371/journal.pntd.0004543 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Ayres CFJ. Identification of Zika virus vectors and implications for control. Lancet Infect Dis. 2016;16(3): 278–279. doi: 10.1016/S1473-3099(16)00073-6 [DOI] [PubMed] [Google Scholar]
  • 27.Azar SR, Diaz-Gonzalez EE, Danis-Lonzano R, Fernandez-Salas I, Weaver SC. Naturally infected Aedes aegypti collected during a Zika virus outbreak have viral titres consistent with transmission. Emerg Microbes Infect. 2019;8(1): 242–244. doi: 10.1080/22221751.2018.1561157 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Fernandes RS, Campos SS, Ferreira-de-Brito A, Miranda RM, Silva KAB, Castro MG, et al. Culex quinquefasciatus from Rio de Janeiro is not competent to transmit the local Zika virus. PLoS Negl Trop Dis. 2016;10(9): e0004993. doi: 10.1371/journal.pntd.0004993 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Gomard Y, Lebon C, Mavingui P, Atyame CM. Contrasted transmission efficiency of Zika virus strains by mosquito species Aedes aegypti, Aedes albopictus and Culex quinquefasciatus from Reunion Island. Parasit Vectors. 2020, 13(1): 398. doi: 10.1186/s13071-020-04267-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Guedes DR, Paiva MH, Donato MM, Barbosa PP, Krokovsky L, Rocha SWS, et al. Zika virus replication in the mosquito Culex quinquefasciatus in Brazil. Emerg Microbes Infect. 2017;6(8): e69. doi: 10.1038/emi.2017.59 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Guo X, Li C, Deng Y, Xing D, Liu Q, Wu Q, et al. Culex pipiens quinquefasciatus: a potential vector to transmit Zika virus. Emerg Microbes Infect. 2016;5(9): e102. doi: 10.1038/emi.2016.102 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Heitmann A, Jansen S, Lühken R, Leggewie M, Badusche M, Pluskota B, et al. Experimental transmission of Zika virus by mosquitoes from central Europe. Euro Surveill. 2017;22(2): 30437. doi: 10.2807/1560-7917.ES.2017.22.2.30437 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Main BJ, Nicholson J, Winokur OC, Steiner C, Riemersma KK, Stuart J, et al. Vector competence of Aedes aegypti, Culex tarsalis, and Culex quinquefasciatus from California for Zika virus. PLoS Negl Trop Dis. 2018;12(6): e0006524. doi: 10.1371/journal.pntd.0006524 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Bellini R, Medici A, Calzolari M, Bonilauri P, Cavrini F, Sambri V, et al. Impact of chikungunya virus on Aedes albopictus females and possibility of vertical transmission using the actors of the 2007 outbreak in Italy. PLoS One. 2012;7(2): e28360. doi: 10.1371/journal.pone.0028360 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Zink SD, van Slyke GA, Palumbo MJ, Kramer LD, Ciota AT. Exposure to West Nile virus increases bacterial diversity and immune gene expression in Culex pipiens. Viruses. 2015;7(10): 5619–5631. doi: 10.3390/v7102886 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Phumee A, Chompoosri J, Intayot P, Boonserm R, Boonyasuppayakorn S, Buathong R, et al. Vertical transmission of Zika virus in Culex quinquefasciatus Say and Aedes aegypti (L.) mosquitoes. Sci Rep. 2019;9: 5257. doi: 10.1038/s41598-019-41727-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.National Meteorology Institute (INMET). Brazilian Climatological Standards: Period 1991–2020. 2023. [cited 10 October 2023]. In: Inmet Portal. Brasilia Brazil: INMET. Available from: https://portal.inmet.gov.br/normais. [Google Scholar]
  • 38.Barbosa RMR, Regis LN. Monitoring temporal fluctuations of Culex quinquefasciatus using oviposition traps containing attractant and larvicide in an urban environment in Recife, Brazil. Mem Inst Oswaldo Cruz. 2011;106(4): 451–455. doi: 10.1590/S0074-02762011000400011 [DOI] [PubMed] [Google Scholar]
  • 39.Meneses JA, Ishigami AC, Mello LM, Albuquerque LL, Brito CAA, Cordeiro MT, et al. Lessons Learned at the Epicenter of Brazil’s Congenital Zika Epidemic: Evidence From 87 Confirmed Cases. Clin Infect Dis. 2017;64(10): 1302–1308. doi: 10.1093/cid/cix166 [DOI] [PubMed] [Google Scholar]
  • 40.Melo-Santos MAV, Sanches EG, Jesus FJ, Regis L. Evaluation of a new tablet formulation based on Bacillus thuringiensis sorovar. israelensis for larvicidal control of Aedes aegypti. Mem Inst Oswaldo Cruz. 2001; 96(6): 859–860. doi: 10.1590/S0074-02762001000600020 [DOI] [PubMed] [Google Scholar]
  • 41.Amorim LB, Helvecio E, Oliveira CMF, Ayres CFJ. Susceptibility status of Culex quinquefasciatus (Diptera: Culicidae) populations to the chemical insecticide temephos in Pernambuco, Brazil. Pest Manag Sci. 2013;69(12): 1307–1314. doi: 10.1002/ps.3502 [DOI] [PubMed] [Google Scholar]
  • 42.Donald CL, Brennan B, Cumberworth SL, Rezelj VV, Clark JJ, Cordeiro MT, et al. Full Genome Sequence and sfRNA Interferon Antagonist Activity of Zika Virus from Recife, Brazil. PLoS Negl Trop Dis. 2016;10(10): e0005048. doi: 10.1371/journal.pntd.0005048 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Lanciotti RS, Kosoy OL, Laven JJ, Panella AJ, Velez JO, Lambert AJ, et al. Chikungunya virus in US travelers returning from India, 2006. Emerg Infect Dis. 2007;13(5): 764–767. doi: 10.3201/eid1305.070015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Lanciotti RS, Kosoy OL, Laven JJ, Velez JO, Lambert AJ, Stanfield SM, et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis. 2008;14(8): 1232–1239. doi: 10.3201/eid1408.080287 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Kong YY, Thay CH, Tin TC, Devi S. Rapid detection, serotyping and quantification of dengue viruses by TaqMan real-time one-step RT-PCR. J Virol Methods. 2006;138(1–2): 123–130. doi: 10.1016/j.jviromet.2006.08.003 [DOI] [PubMed] [Google Scholar]
  • 46.The R Foundation. The R Project: a language and environment for statistical computing. 2023. [cited 10 October 2023]. In: r-project.org [Internet]. Vienna, Austria: The R Foundation. Available from: https://www.R-project.org/. [Google Scholar]
  • 47.Silveira ID, Petersen MT, Sylvestre G, Garcia GA, David MR, Pavan MG, et al. Reduction on Aedes aegypti lifespan but no effects on mosquito fecundity and oviposition success. Front Microbiol. 2018;9: 3011. doi: 10.3389/fmicb.2018.03011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Reiskind MH, Westbrook CJ, Lounibos LP. Exposure to chikungunya virus and adult longevity in Aedes aegypti (L.) and Aedes albopictus (Skuse). J Vector Ecol. 2010;35(1): 61–68. doi: 10.1111/j.1948-7134.2010.00029.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Bowers DF, Abell BA, Brown DT. Replication and tissue tropism of the alphavirus sindbis in the mosquito Aedes albopictus. Virology. 1995;212(1): 1–12. doi: 10.1006/viro.1995.1447 [DOI] [PubMed] [Google Scholar]
  • 50.Girard YA, Klingler KA, Higgs S. West Nile virus dissemination and tissue tropisms in orally infected Culex pipiens quinquefasciatus. Vector-Borne Zoonotic Dis. 2004;4(2): 109–122. doi: 10.1089/1530366041210729 [DOI] [PubMed] [Google Scholar]
  • 51.Li C, Guo X, Deng Y, Xing D, Sun A, Liu Q, et al. Vector competence and transovarial transmission of two Aedes aegypti strains to Zika virus. Emerg Microbes Infect. 2017;6(4): e23. doi: 10.1038/emi.2017.8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Ciota AT, Ehrbar DJ, Matacchiero AC, van Slyke GA, Kramer LD. The evolution of virulence of West Nile virus in a mosquito vector: Implications for arbovirus adaptation and evolution. BMC Evol Biol. 2013;13: 71. doi: 10.1186/1471-2148-13-71 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Mahmood F, Reisen WK, Chiles RE, Fang Y. Western equine encephalomyelitis virus infection affects the life table characteristics of Culex tarsalis (Diptera: Culicidae). J Med Entomol. 2004;41(5): 982–986. doi: 10.1603/0022-2585-41.5.982 [DOI] [PubMed] [Google Scholar]
  • 54.Fuller TL, Calvet G, Genaro Estevam C, Rafael Angelo J, Abiodun GJ, Halai UA, et al. Behavioral, climatic, and environmental risk factors for Zika and chikungunya virus infections in Rio de Janeiro, Brazil, 2015–16. PLoS One. 2017;12(11): e0188002. doi: 10.1371/journal.pone.0188002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Nag DK, Payne AF, Dieme C, Ciota AT, Kramer LD. Zika virus infects Aedes aegypti ovaries. Virology. 2021;561: 58–64. doi: 10.1016/j.virol.2021.06.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Cui Y, Grant DG, Lin J, Yu X, Franz AWE. Zika virus dissemination from the midgut of Aedes aegypti is facilitated by bloodmeal-mediated structural modification of the midgut basal lamina. Viruses. 2019;11(11): 1056. doi: 10.3390/v11111056 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Honório NA, Wiggins K, Eastmond B, Câmara DCP, Alto BW. Experimental Vertical Transmission of Chikungunya Virus by Brazilian and Florida Aedes albopictus Populations. Viruses. 2019;11(4): 353. doi: 10.3390/v11040353 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Kelli L Barr

18 May 2023

PONE-D-23-02967Exposure to Zika and chikungunya viruses impacts aspects of the vectorial capacity of Aedes aegypti and Culex quinquefasciatusPLOS ONE

Dear Dr. Guedes,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jul 02 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Kelli L. Barr, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. 

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

3. Thank you for stating the following in your Competing Interests section:  "The authors declare no conflict of interest"

Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state "The authors have declared that no competing interests exist.", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now 

This information should be included in your cover letter; we will change the online submission form on your behalf.

4. Please amend the manuscript submission data (via Edit Submission) to include author: Constância Ayres

5. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript.

Additional Editor Comments:

Two of the reviewers raised significant concerns about the results with reviewer 3 raising the most important issues. It looks like you are comparing 2 different populations of mosquitoes that have been treated differently. This must be clarified.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

Reviewer #3: No

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: In the following manuscript by Crespo and colleagues entitled “Exposure to Zika and chikungunya viruses impacts aspects of the vectorial capacity of Aedes aegypti and Culex quinquefasciatus”, the authors examined the effect of CHIKV and ZIKV infection on the vectorial capacity of natural and laboratory stablished colonies of Ae. aegypti and Culex quinquefasciatus. Their results found that CHIKV and ZIKV altered some biological parameters in Ae. aegypti and Culex quinquefasciatus including fecundity, fertility, survival, longevity, and blood feeding status. These results provide a better understanding over the processes of virus-vector interaction and can shed light on the complexity of arbovirus transmission.

Elucidating the mechanisms of viral and vector interactions that determine the vector competence of insect species such as mosquitoes is critical to understand the dynamics of transmission of these viruses among vector populations and their transmission to human hosts. This manuscript by Crespo and colleagues addressed some biological aspects of the arbovirus infections of highly anthropogenic and competent mosquito species, Aedes aegypti and Culex quinquefasciatus from an area with high transmission for ZIKV and CHIKV such as the case of Brazil. The manuscript is well-written and the results well-described; however, these are still some aspects that needed to be clarified by the authors as noticed below:

Major(s)

1. Knowing that the vertical transmission of arboviruses such as dengue virus (DENV), ZIKV and CHIKV may occur in endemic areas; were natural isolated colonies of Ae. aegypti previously tested for DENV infection? This is important to know as pre-established viral infections in mosquito populations may affect their vectorial capacity once evaluated under laboratory conditions? RT-PCR? Was any other marker of arboviral infection is mosquitoes used?

2. Knowing the maturation stage that occur in flavivirus virions such as ZIKV and DENV once grown in either mammalian (e.g., Vero) or insect cells (C6/36 cells), was any experiment performed using viruses derived from infected mosquito cells?

3. For viral infection of both mosquito species, the authors used as negative control a mixture of equal volume of virus free cell culture and defibrinated rabbit blood; however, knowing that viral replication after infection of mosquitos would be the main cause of the altered biological parameters in mosquitoes, would not be better using inactivated viruses during blood feeding experiments instead?

4. In the methods section the authors stated that “Whole mosquitoes were processed, except for Ae. aegypti collected at 7 dpe, whose abdomens and thorax were analyzed separately from the heads. How is that these important data was not included at least as a supporting information in this manuscript? This is a critical biological parameter for measuring vector competence and the level of viral infection (e.g., viral RNA load, viral genome equivalents, etc) detected in each individual mosquito that may affect the conclusions described in the manuscript. Please clarify this and add this set of data to the manuscript.

Reviewer #2: Peer Review for:

Manuscript Number: PONE-D-23-02967

Manuscript Title: Exposure to Zika and chikungunya viruses impacts aspects of the vectorial capacity of Aedes aegypti and Culex quinquefasciatus

In their manuscript Crespo et al explore the impact of ZIKV and CHIKV arbovirus exposure and infection on reproductive capacity, longevity, and blood feeding of Aedes aegypti and Culex quinquefasciatus mosquitoes. They accomplish this by exposing lab and field-caught colonies of Ae. aegypti to both ZIKV and CHIKV, and a lab colony of Cx. quinquefasciatus to ZIKV and then assessing fecundity and fertility. To evaluate survival and longevity, the authors collected Ae. aegypti mosquitoes at 7, 14, and 21 days post exposure, but only collected Cx. quinquefasciatus when death occurred throughout the experiment. FTA cards infused with Manuka honey blend were utilized for viral detection. Additionally, blood-seeking behavior was assessed at 7, 14, and 21 days post exposure. RT-qPCR was performed for viral detection of the samples. While it’s significant that both viruses were associated with a biological cost, in particular, diminished reproductive capability, the fact that blood feeding activity remained the same (or even increased) after exposure helps further explain viral dissemination and global expansion of these arboviruses.

Major Issues:

Line 170-171 - Why were Cx. quinquefasciatus mosquitoes treated differently (evaluated differently) from Ae. aegypti?

Line 244-247 - More information is needed concerning the contamination of samples and inability to carry out 2nd and 3rd experiments. Did you consider re-running the experiment for the sake of replication?

Figures 1-3 are not visible on the downloaded PDF.

Minor Issues:

Please see my edited version of your manuscript with highlights and comments.

Line 28 – no period is needed after “AeCamp”

Line 38-39 – consider defining “vectorial capacity” a bit here. You may also consider differentiating “vectorial capacity” from “vector competence”

Line 41-43 – The cited study involves Anopheles mosquitoes and doesn’t relate well as an “example” of what you previously stated.

Line 67 – “vector” should read “vectorial”

Line 68-70 – consider re-wording this sentence as it is hard to understand

Line 71 – use commas instead of semicolons.

Line 83-84 – This could use a reference.

Line 100 – What is “shelling”?

Line 113 – “tittered” should be “titered”

Line 181 – Consider including the timeframe that mosquitoes were allowed to seek a blood meal.

For Figure captions, please include a clear description of what group each panel represents. For example, you do this in Fig 5 caption (A: RecL Colony; B: AeCamp Colony), but not clearly for Fig 4.

Line 359 – Consider “blood feeding” instead of “blood meal activity”

Line 377 – remove the “a”.

Line 494 – Consider changing “of control of” to “to control”

Overall, this is a well designed and executed study to further explore the biological cost of arbovirus exposure and the impact of infection on vectorial capacity. Recommend acceptance for publication after minor revisions.

Reviewer #3: The paper discusses such an important issue, the effects of arbovirus on the biology of two insect vectors, Aedes aegypti, and Culex quinquefasciatus. Despite the interesting question, some details should be clarified.

It was challenging to analyze the results as the materials and methods needed to be clarified. It seems the authors made lots of exceptions in the experimental designs. If it is not a description problem, the results are not comparable because they were not made the same way.

Introduction

Lines 41 – 43: “For example, the number of eggs produced in the first gonotrophic cycle indicates the total lay profile during the entire female life in mosquitoes [10].” I think some more recent references do not confirm this statement. Can you check this information?

Materials and methods

Lines 116 – 117: “For Ae. aegypti, each experiment was performed with two groups for each colony (RecL, 117 AeCamp, and CqSLab)”. CqSLab is a colony of C. quinquesfasciatus, isn’t it? I presume you meant one of the viruses, right? This point needs to be clarified.

Lines 133 – 134: How did you group the exposed but not infected (E) samples for ZIKV? Did you check all the mosquitoes individually to split them into the E and EI groups? This point needs to be clarified.

Lines 136 – 140: Did you discard the E group for CHIKV or join them with the EI group?

Lines 170 – 174: Survival and longevity assessment in Culex – why didn’t you repeat the same experimental design as Aedes? Why didn’t you collect samples at 7, 14, and 21 DPE?

Lines 182 – 184: “For Cx.quinquefasciatus exposed to ZIKV and Ae. aegypti exposed to CHIKV, evaluations were carried out exclusively with the first post-exposure blood meal (7 dpe).”. Again, a variation in the experimental design happens here. Why didn’t you perform the experiments in the same way? It should be stated in the M&M section if it was a methodological problem.

Lines 185-210: RNA extraction and qPCR assays: a) I need clarification on whether you tested all the females or only the females collected at 7, 14, and 21 dpe. b) “To calculate the infection rate (IR), the number of positive females was divided by the total number of analyzed samples” What is the size of the samples? c) regarding the section ‘Assessment of the biological parameters after exposure to viruses,’ did you calculate the IR based on subsamples?

The viral detection of females needs a more precise explanation.

Lines 223-225: This reference should be in the References Section.

Results

Lines 258-267: what is the total number of females analyzed in each group?

Lines 283 – 286: I didn’t find the data related to Cx. quinquefasciatus females infected females in the Supplementary tables.

(S1 Table. Risk of death for females of Ae. aegypti, RecL and AeCamp colonies, after exposure to Zika virus (ZIKV); S2 Table. Risk of death for females from the laboratory Aedes aegypti colony – RecL after exposure to chikungunya virus (CHIKV) during the first 20 days of observation; S3 Table. Risk of death for females from the field colony of Aedes aegypti – AeCamp after exposure to chikungunya virus (CHIKV).)

Lines 288 – 291: The line format used in the graphs is very confusing. Can you change them to avoid confusion?

Discussion

In general, the discussion section is superficial. The data presented sometimes supports and sometimes disagrees with the data in the literature. Still, it needs to be clarified what is the actual contribution of the findings to the vector-host interaction area.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Henry Puerta-Guardo

Reviewer #2: Yes: Mark F. Olson

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: PONE-D-23-02967.pdf

pone.0281851.s002.pdf (1.2MB, pdf)
Attachment

Submitted filename: Review.docx

pone.0281851.s003.docx (14.4KB, docx)
PLoS One. 2024 May 15;19(5):e0281851. doi: 10.1371/journal.pone.0281851.r002

Author response to Decision Letter 0


9 Oct 2023

Dear Kelli L. Barr,

Academic Editor PLOS ONE

We thank you and three reviewers for improving our manuscript. Here is our answer to each question raised during manuscript review.

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

R: Thanks, we have done that

2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

R: We have corrected that

3. Thank you for stating the following in your Competing Interests section: "The authors declare no conflict of interest"

Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state "The authors have declared that no competing interests exist.", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now

This information should be included in your cover letter; we will change the online submission form on your behalf.

R: We have done that

4. Please amend the manuscript submission data (via Edit Submission) to include author: Constância Ayres

R: My name is already there. I am the last author.

5. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript.

R: We have corrected that

Additional Editor Comments:

Two of the reviewers raised significant concerns about the results with reviewer 3 raising the most important issues. It looks like you are comparing 2 different populations of mosquitoes that have been treated differently. This must be clarified.

R: We have answered these issues

[Note: HTML markup is below. Please do not edit Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

Reviewer #3: No

R: We have changed the conclusion paragraph at the end of the discussion section

________________________________________

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: No

R: We have performed more statistical analysis and added to the manuscript

________________________________________

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: Yes

R: We have added more data in Supplementary material

Author’s feedback: tables with data on the number of samples, standard deviation, means, medians and variance measures are now available in the supplementary material. The citations of the referred tables were inserted throughout the manuscript.

________________________________________

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: No

R: We have corrected minor errors

________________________________________

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: In the following manuscript by Crespo and colleagues entitled “Exposure to Zika and chikungunya viruses impacts aspects of the vectorial capacity of Aedes aegypti and Culex quinquefasciatus”, the authors examined the effect of CHIKV and ZIKV infection on the vectorial capacity of natural and laboratory stablished colonies of Ae. aegypti and Culex quinquefasciatus. Their results found that CHIKV and ZIKV altered some biological parameters in Ae. aegypti and Culex quinquefasciatus including fecundity, fertility, survival, longevity, and blood feeding status. These results provide a better understanding over the processes of virus-vector interaction and can shed light on the complexity of arbovirus transmission.

Elucidating the mechanisms of viral and vector interactions that determine the vector competence of insect species such as mosquitoes is critical to understand the dynamics of transmission of these viruses among vector populations and their transmission to human hosts. This manuscript by Crespo and colleagues addressed some biological aspects of the arbovirus infections of highly anthropogenic and competent mosquito species, Aedes aegypti and Culex quinquefasciatus from an area with high transmission for ZIKV and CHIKV such as the case of Brazil. The manuscript is well-written and the results well-described; however, these are still some aspects that needed to be clarified by the authors as noticed below:

Major(s)

1. Knowing that the vertical transmission of arboviruses such as dengue virus (DENV), ZIKV and CHIKV may occur in endemic areas; were natural isolated colonies of Ae. aegypti previously tested for DENV infection? This is important to know as pre-established viral infections in mosquito populations may affect their vectorial capacity once evaluated under laboratory conditions? RT-PCR? Was any other marker of arboviral infection is mosquitoes used?

R: Yes, It is a protocol in our lab to test pools of mosquitoes collected in the field for arbovirus and Wolbachia before establishing our colonies. So far, we have observed that vertical transmission is a very rare event and we found no positive sample for that colony. Besides, we did not use the F0 generation we have used F2.

2. Knowing the maturation stage that occur in flavivirus virions such as ZIKV and DENV once grown in either mammalian (e.g., Vero) or insect cells (C6/36 cells), was any experiment performed using viruses derived from infected mosquito cells?

R: No. We chose to use only virus grown in Vero cells, considering that a clear cytopathic effect is observed after infection in this particular type of cell.

3. For viral infection of both mosquito species, the authors used as negative control a mixture of equal volume of virus free cell culture and defibrinated rabbit blood; however, knowing that viral replication after infection of mosquitos would be the main cause of the altered biological parameters in mosquitoes, would not be better using inactivated viruses during blood feeding experiments instead?

R: We are not sure that viral replication is the main cause, or only the exposure to viruses after blood ingestion, without necessarily having infection and consequent replication (Styer, Meola and Kramer, 2007). Thus, with regard to the control, we chose to use blood free of viral particles.

4. In the methods section the authors stated that “Whole mosquitoes were processed, except for Ae. aegypti collected at 7 dpe, whose abdomens and thorax were analyzed separately from the heads. How is that these important data was not included at least as a supporting information in this manuscript? This is a critical biological parameter for measuring vector competence and the level of viral infection (e.g., viral RNA load, viral genome equivalents, etc) detected in each individual mosquito that may affect the conclusions described in the manuscript. Please clarify this and add this set of data to the manuscript.

R: Thanks for this. We agree with reviewer, and we have performed a new analysis of correlation using this information and added to the supporting information.

Reviewer #2: Peer Review for: Manuscript Number: PONE-D-23-02967 Manuscript Title: Exposure to Zika and chikungunya viruses impacts aspects of the vectorial capacity of Aedes aegypti and Culex quinquefasciatus

In their manuscript Crespo et al explore the impact of ZIKV and CHIKV arbovirus exposure and infection on reproductive capacity, longevity, and blood feeding of Aedes aegypti and Culex quinquefasciatus mosquitoes. They accomplish this by exposing lab and field-caught colonies of Ae. aegypti to both ZIKV and CHIKV, and a lab colony of Cx. quinquefasciatus to ZIKV and then assessing fecundity and fertility. To evaluate survival and longevity, the authors collected Ae. aegypti mosquitoes at 7, 14, and 21 days post exposure, but only collected Cx. quinquefasciatus when death occurred throughout the experiment. FTA cards infused with Manuka honey blend were utilized for viral detection. Additionally, blood-seeking behavior was assessed at 7, 14, and 21 days post exposure. RT-qPCR was performed for viral detection of the samples. While it’s significant that both viruses were associated with a biological cost, in particular, diminished reproductive capability, the fact that blood feeding activity remained the same (or even increased) after exposure helps further explain viral dissemination and global expansion of these arboviruses.

Major Issues:

1 - Line 170-171 - Why were Cx. quinquefasciatus mosquitoes treated differently (evaluated differently) from Ae. aegypti?

R: Data from experiments carried out by our group show a lower rate of ZIKV infection in Cx. quinquefasciatus when compared to Ae. aegypti. Thus, with the purpose of ensuring a minimum number of infected females for longevity assessment, we decided to collect the samples as the mosquitoes died, instead of collecting them at the three time points (7, 14 and 21 days). We clarify that the main objective of this study was to evaluate the biological cost after exposure and infection to the viruses and not to compare this cost between the evaluated species.

2 - Line 244-247 - More information is needed concerning the contamination of samples and inability to carry out 2nd and 3rd experiments. Did you consider re-running the experiment for the sake of replication?

R: Contamination was detected by RT-qPCR. We have changed the sentence in the manuscript. Considering that each experiment, in this case, takes around 60 days to finish and that the main objective of this study was to evaluate the post-exposure and infection biological cost and not the rate of transmission, we chose to proceed with the assessments with the data we had available and not repeat the experiments.

3 - Figures 1-3 are not visible on the downloaded PDF.

R: We have corrected it.

Minor Issues:

Please see my edited version of your manuscript with highlights and comments.

4 - Line 28 – no period is needed after “AeCamp”.

R Done.

5 - Line 38-39 – consider defining “vectorial capacity” a bit here. You may also consider differentiating “vectorial capacity” from “vector competence”.

R Done.

6 - Line 41-43 – The cited study involves Anopheles mosquitoes and doesn’t relate well as an “example” of what you previously stated.

R The citation was removed from the text.

7 - Line 67 – “vector” should read “vectorial”.

R Done.

8 - Line 68-70 – consider re-wording this sentence as it is hard to understand.

R Done.

9 - Line 71 – use commas instead of semicolons.

R Done.

10 - Line 83-84 – This could use a reference.

R The citation was included in the text.

11 - Line 100 – What is “shelling”?

R This was wrong, we have corrected it in the text.

12 - Line 113 – “tittered” should be “titered”.

R Done.

13 - Line 181 – Consider including the timeframe that mosquitoes were allowed to seek a blood meal.

R Thank you. We have included it.

14 - For Figure captions, please include a clear description of what group each panel represents. For example, you do this in Fig 5 caption (A: RecL Colony; B: AeCamp Colony), but not clearly for Fig 4.

R Done.

15 - Line 359 – Consider “blood feeding” instead of “blood meal activity”

Line 377 – remove the “a”.

R Done.

16 - Line 494 – Consider changing “of control of” to “to control”.

R Done.

Overall, this is a well designed and executed study to further explore the biological cost of arbovirus exposure and the impact of infection on vectorial capacity. Recommend acceptance for publication after minor revisions.

Reviewer #3: The paper discusses such an important issue, the effects of arbovirus on the biology of two insect vectors, Aedes aegypti, and Culex quinquefasciatus. Despite the interesting question, some details should be clarified.

It was challenging to analyze the results as the materials and methods needed to be clarified. It seems the authors made lots of exceptions in the experimental designs. If it is not a description problem, the results are not comparable because they were not made the same way.

Introduction

1 - Lines 41 – 43: “For example, the number of eggs produced in the first gonotrophic cycle indicates the total lay profile during the entire female life in mosquitoes [10].” I think some more recent references do not confirm this statement. Can you check this information?

R The example was used to justify that the assessment of the first gonadotrophic cycle is relevant, as it represents the profile of the female throughout her life. However, we agree that it is out of context. We have deleted from the text.

Materials and methods

2 - Lines 116 – 117: “For Ae. aegypti, each experiment was performed with two groups for each colony (RecL, 117 AeCamp, and CqSLab)”. CqSLab is a colony of C. quinquesfasciatus, isn’t it? I presume you meant one of the viruses, right? This point needs to be clarified.

R We meant that “each experiment was carried out with two groups for each colony (RecL, AeCamp and CqSLab): exposed to the virus (E) and not exposed (NE, control group)”. We have corrected in the text.

3 - Lines 133 – 134: How did you group the exposed but not infected (E) samples for ZIKV? Did you check all the mosquitoes individually to split them into the E and EI groups? This point needs to be clarified.

R Yes, we did run RT-qPCR for all mosquitoes individually and then separated those that were negative (exposed but not infected - E) and positive (exposed infected - EI). The information has been included in the text.

4 - Lines 136 – 140: Did you discard the E group for CHIKV or join them with the EI group?

R We have discarded group E, as the number of individuals was too small (the infection rate was too high – around 90%). The information has been included in the text.

5 - Lines 170 – 174: Survival and longevity assessment in Culex – why didn’t you repeat the same experimental design as Aedes? Why didn’t you collect samples at 7, 14, and 21 DPE?

R Plea

Attachment

Submitted filename: Response_PointbyPoint 06102023.docx

pone.0281851.s004.docx (31.6KB, docx)

Decision Letter 1

Kelli L Barr

2 Nov 2023

PONE-D-23-02967R1Exposure to Zika and chikungunya viruses impacts aspects of the vectorial capacity of Aedes aegypti and Culex quinquefasciatusPLOS ONE

Dear Dr. Ayres,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

The reviewers made points that need to be clarified or expanded upon to ensure your conclusions have the appropriate support.

Please submit your revised manuscript by Dec 17 2023 11:59PM If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Kelli L. Barr, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

Reviewer #3: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: No

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #2: Review for Revision 1 of:

Manuscript Number: PONE-D-23-02967

Manuscript Title: Exposure to Zika and chikungunya viruses impacts aspects of the vectorial capacity of Aedes aegypti and Culex quinquefasciatus

Additional Minor Issues:

Line 50 – Add space before “Modifications”

Line 54 – Flaviviridae and Togaviridae should both be italicized ( Flaviviridae and Togaviridae )

Line 88 – Add a period.

In the “Study Area” section, consider adding avg. annual precipitation.

Line 92 – remove “and”

Line 102 – delete duplicate “and”

Line 103 – delete space and 1 “.” after the word “dipper”

Line 167 – use a comma, not a semicolon as in line 173.

Line 231 – no ‘ needed after “Wallis”

Table 2 is difficult to interpret; data doesn’t seem to fit correctly. Be consistent. Some numbers use “e” others “E” and 2 of the numbers just have a long string of integers.

Consider just using decimal points for the numbers in your tables, not commas.

Line 359 – 360 – delete the space between 63.48 and the “%” as well as with 40.67

Line 363 – add % after 57.50 and 37.50

Line 400 – delete extra comma after “6”

Line 460 – I believe the word you intend, throughout the paper is “gonotrophic” as opposed to gonadotropic or gonadotrophic. Consider using gonotrophic at line 134, 157, 162, 168, Fig 4 legend, 370, and 460.

Line 540 – It is worth highlighting…

Line 543 – “pointed out” of better, “discussed” or “elucidated”

Reviewer #3: The manuscript has improved after the suggestions made by the reviewers, and I thank the authors for that. However, I still have some considerations about the data and the conclusions made.

The authors wrote in the Discussion section: “In summary, despite the significant reduction in some aspects of the biological performance of Ae. aegypti, for both viruses and for Cx. quinquefasciatus, infected with ZIKV, our data suggest that their vectorial capacity is probably not affected, as the longevity and feeding behavior of field mosquitoes were not impacted by virus.” They also mention that the data presented in the manuscript corroborated other published data. Were the authors expecting any different results? Why or why not? Would you expect to find any differences in mosquitoes from the field? If so, do you have any hypothesis to explain why it did not happen? Sorry if I am being repetitive, but I still miss some sentences describing the new relevant data of this manuscript.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Henry Puerta-Guardo

Reviewer #2: No

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Review of Revision_Reviewer 2.docx

pone.0281851.s005.docx (13.1KB, docx)
PLoS One. 2024 May 15;19(5):e0281851. doi: 10.1371/journal.pone.0281851.r004

Author response to Decision Letter 1


19 Dec 2023

Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: Review for Revision 1 of:

Manuscript Number: PONE-D-23-02967

Manuscript Title: Exposure to Zika and chikungunya viruses impacts aspects of the vectorial capacity of Aedes aegypti and Culex quinquefasciatus

Additional Minor Issues:

Line 50 – Add space before “Modifications”

Author's response to reviewer: done

Line 54 – Flaviviridae and Togaviridae should both be italicized (Flaviviridae and Togaviridae )

Author's response to reviewer: done

Line 88 – Add a period.

Author's response to reviewer: done

In the “Study Area” section, consider adding avg. annual precipitation.

Author's response to reviewer: done

Line 92 – remove “and”

Author's response to reviewer: done

Line 102 – delete duplicate “and”

Author's response to reviewer: done

Line 103 – delete space and 1 “.” after the word “dipper”

Author's response to reviewer: done

Line 167 – use a comma, not a semicolon as in line 173.

Author's response to reviewer: done

Line 231 – no ‘ needed after “Wallis”

Author's response to reviewer: done

Table 2 is difficult to interpret; data doesn’t seem to fit correctly. Be consistent. Some numbers use “e” others “E” and 2 of the numbers just have a long string of integers.

Consider just using decimal points for the numbers in your tables, not commas.

Author's response to reviewer: done

Line 359 – 360 – delete the space between 63.48 and the “%” as well as with 40.67

Author's response to reviewer: done

Line 363 – add % after 57.50 and 37.50

Author's response to reviewer: done

Line 400 – delete extra comma after “6”

Author's response to reviewer: done

Line 460 – I believe the word you intend, throughout the paper is “gonotrophic” as opposed to gonadotropic or gonadotrophic. Consider using gonotrophic at line 134, 157, 162, 168, Fig 4 legend, 370, and 460.

Author's response to reviewer: done

Line 540 – It is worth highlighting…

Author's response to reviewer: done

Line 543 – “pointed out” of better, “discussed” or “elucidated”

Author's response to reviewer: done

Reviewer #3:

The manuscript has improved after the suggestions made by the reviewers, and I thank the authors for that. However, I still have some considerations about the data and the conclusions made.

The authors wrote in the Discussion section: “In summary, despite the significant reduction in some aspects of the biological performance of Ae. aegypti, for both viruses and for Cx. quinquefasciatus, infected with ZIKV, our data suggest that their vectorial capacity is probably not affected, as the longevity and feeding behavior of field mosquitoes were not impacted by virus.” They also mention that the data presented in the manuscript corroborated other published data. Were the authors expecting any different results? Why or why not? Would you expect to find any differences in mosquitoes from the field? If so, do you have any hypothesis to explain why it did not happen? Sorry if I am being repetitive, but I still miss some sentences describing the new relevant data of this manuscript.

Author's response to reviewer: We changed the last paragraph of the discussion to clarify these issues.

Attachment

Submitted filename: Response 2_PointbyPoint 12152023.docx

pone.0281851.s006.docx (18.5KB, docx)

Decision Letter 2

Kelli L Barr

2 Jan 2024

PONE-D-23-02967R2Exposure to Zika and chikungunya viruses impacts aspects of the vectorial capacity of Aedes aegypti and Culex quinquefasciatusPLOS ONE

Dear Dr. Ayres,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Your paper is much improved but there are a few issues that require clarification. Reviewer 2 identified minor grammatical and formatting errors that must be addressed.  Reviewer 3 raised questions regarding your conclusions. Addressing these questions will support your conclusions.

Please submit your revised manuscript by Feb 16 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Kelli L. Barr, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 May 15;19(5):e0281851. doi: 10.1371/journal.pone.0281851.r006

Author response to Decision Letter 2


5 Apr 2024

Dear Editor

As I mentioned before, we did not receive the comments from the reviewers, so we are submitting the files again.

Attachment

Submitted filename: Response 2_PointbyPoint 12152023.docx

pone.0281851.s007.docx (18.5KB, docx)

Decision Letter 3

Kelli L Barr

15 Apr 2024

Exposure to Zika and chikungunya viruses impacts aspects of the vectorial capacity of Aedes aegypti and Culex quinquefasciatus

PONE-D-23-02967R3

Dear Dr. Ayres,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Kelli L. Barr, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File

    (DOCX)

    pone.0281851.s001.docx (295.7KB, docx)
    Attachment

    Submitted filename: PONE-D-23-02967.pdf

    pone.0281851.s002.pdf (1.2MB, pdf)
    Attachment

    Submitted filename: Review.docx

    pone.0281851.s003.docx (14.4KB, docx)
    Attachment

    Submitted filename: Response_PointbyPoint 06102023.docx

    pone.0281851.s004.docx (31.6KB, docx)
    Attachment

    Submitted filename: Review of Revision_Reviewer 2.docx

    pone.0281851.s005.docx (13.1KB, docx)
    Attachment

    Submitted filename: Response 2_PointbyPoint 12152023.docx

    pone.0281851.s006.docx (18.5KB, docx)
    Attachment

    Submitted filename: Response 2_PointbyPoint 12152023.docx

    pone.0281851.s007.docx (18.5KB, docx)

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES